×
About 3,602 results

ALLMedicine Onychomycosis Center

Research & Reviews  1,477 results

A Phase 2, randomized, double-blind, placebo-controlled, dose-ranging study to evaluate...
https://doi.org/10.1111/bjd.19224
The British Journal of Dermatology; Elewski B, Brand S et. al.

May 18th, 2020 - Onychomycosis is a fungal disease that affects the fingernails and toenails and is predominantly caused by dermatophytes. VT-1161 is a novel inhibitor of fungal CYP51 through the inhibition of the lanosterol demethylase, and has demonstrated poten...

Labelled use of efinaconazole topical solution 10% in treating onychomycosis in childre...
https://doi.org/10.1111/dth.13613
Dermatologic Therapy; Gupta AK, Venkataraman M et. al.

May 17th, 2020 - Until recently, there was no FDA-approved antifungal treatment for onychomycosis in children. There is evidence regarding the safety and efficacy of topical antifungal agents for pediatric onychomycosis. To summarize the results of a recent study ...

Fractional CO2-assisted photodynamic therapy improves the clinical outcome and patient'...
https://doi.org/10.1080/09546634.2020.1771252
The Journal of Dermatological Treatment; Abdallah M, Abu-Ghali MM et. al.

May 17th, 2020 - Background: Device-based therapies have been used for onychomycosis patients with intolerance to systemic treatments. Photodynamic therapy (PDT) improves onychomycosis, while fractional carbon dioxide (FrCO2) augments the topical drug delivery. Co...

Retrospective Analysis of Laboratory Abnormalities in Patients Prescribed Terbinafine f...
https://doi.org/10.1016/j.jaad.2020.04.172
Journal of the American Academy of Dermatology; Wang Y, Geizhals S et. al.

May 10th, 2020 - Retrospective Analysis of Laboratory Abnormalities in Patients Prescribed Terbinafine for Onychomycosis.|2020|Wang Y,Geizhals S,Lipner SR,|

Retrospective Study of Factors Affecting Medication Adherence in Patients Prescribed Ef...
https://doi.org/10.1016/j.jaad.2020.04.126
Journal of the American Academy of Dermatology; Wu AG, Geizhals S et. al.

May 3rd, 2020 - Retrospective Study of Factors Affecting Medication Adherence in Patients Prescribed Efinaconazole 10% Solution for Onychomycosis.|2020|Wu AG,Geizhals S,Lipner SR,|

see more →

Guidelines  2 results

Fungal Nail Infections | Fungal Diseases | CDC
https://www.cdc.gov/fungal/nail-infections.html

Jan 24th, 2017 - Fungal nail infections, also called onychomycosis, are common infections of the fingernails or toenails that can cause the nail to become discolored, thick, and more likely to crack and break.

British Association of Dermatologists' guidelines for the management of onychomycosis 2...
https://doi.org/10.1111/bjd.13358
The British Journal of Dermatology; Ameen M, Lear JT et. al.

Nov 20th, 2014 - British Association of Dermatologists' guidelines for the management of onychomycosis 2014.|2014|Ameen M,Lear JT,Madan V,Mohd Mustapa MF,Richardson M,|administration & dosage,diagnosis,drug therapy,surgery,complications,diagnosis,drug therapy,surg...

see more →

Drugs  159 results see all →

Clinicaltrials.gov  1,721 results

A Phase 2, randomized, double-blind, placebo-controlled, dose-ranging study to evaluate...
https://doi.org/10.1111/bjd.19224
The British Journal of Dermatology; Elewski B, Brand S et. al.

May 18th, 2020 - Onychomycosis is a fungal disease that affects the fingernails and toenails and is predominantly caused by dermatophytes. VT-1161 is a novel inhibitor of fungal CYP51 through the inhibition of the lanosterol demethylase, and has demonstrated poten...

Labelled use of efinaconazole topical solution 10% in treating onychomycosis in childre...
https://doi.org/10.1111/dth.13613
Dermatologic Therapy; Gupta AK, Venkataraman M et. al.

May 17th, 2020 - Until recently, there was no FDA-approved antifungal treatment for onychomycosis in children. There is evidence regarding the safety and efficacy of topical antifungal agents for pediatric onychomycosis. To summarize the results of a recent study ...

Fractional CO2-assisted photodynamic therapy improves the clinical outcome and patient'...
https://doi.org/10.1080/09546634.2020.1771252
The Journal of Dermatological Treatment; Abdallah M, Abu-Ghali MM et. al.

May 17th, 2020 - Background: Device-based therapies have been used for onychomycosis patients with intolerance to systemic treatments. Photodynamic therapy (PDT) improves onychomycosis, while fractional carbon dioxide (FrCO2) augments the topical drug delivery. Co...

Retrospective Analysis of Laboratory Abnormalities in Patients Prescribed Terbinafine f...
https://doi.org/10.1016/j.jaad.2020.04.172
Journal of the American Academy of Dermatology; Wang Y, Geizhals S et. al.

May 10th, 2020 - Retrospective Analysis of Laboratory Abnormalities in Patients Prescribed Terbinafine for Onychomycosis.|2020|Wang Y,Geizhals S,Lipner SR,|

Retrospective Study of Factors Affecting Medication Adherence in Patients Prescribed Ef...
https://doi.org/10.1016/j.jaad.2020.04.126
Journal of the American Academy of Dermatology; Wu AG, Geizhals S et. al.

May 3rd, 2020 - Retrospective Study of Factors Affecting Medication Adherence in Patients Prescribed Efinaconazole 10% Solution for Onychomycosis.|2020|Wu AG,Geizhals S,Lipner SR,|

see more →

News  241 results

Nail growth
https://www.mdedge.com/familymedicine/article/218427/oncology/nail-growth?channel=203
MDedge Family Medicine;

Mar 5th, 2020 - The treatment failure with the terbinafine made onychomycosis unlikely, and the appearance of the finger did not suggest that this was a wart. So, the physician opted for a 4-mm punch biopsy of the lateral nail fold, which confirmed that this was.

Expert reviews strategies for diagnosing, treating onychomycosis
https://www.mdedge.com/familymedicine/article/211923/hair-nails/expert-reviews-strategies-diagnosing-treating-onychomycosis?channel=39313
MDedge Dermatology; Doug Brunk

Nov 8th, 2019 - LAS VEGAS – The way Neal Bhatia, MD, sees it, there is no such thing as a classical presentation of onychomycosis. Doug Brunk/MDedge News Dr.

Green thumbnail
https://www.mdedge.com/familymedicine/article/206700/infectious-diseases/green-thumbnail?channel=234
MDedge Family Medicine;

Aug 22nd, 2019 - The patient was given a diagnosis of green nail syndrome (GNS), an infection of the nail bed caused by Pseudomonas aeruginosa. These bacteria produce pyocyanin, a blue-green pigment that discolors the nail.

Onychomycosis that fails terbinafine probably isn’t T. rubrum
https://www.mdedge.com/familymedicine/article/194779/hair-nails/onychomycosis-fails-terbinafine-probably-isnt-t-rubrum?channel=39313
MDedge Dermatology; M. Alexander Otto

Feb 20th, 2019 - WAIKOLOA, HAWAII – The work up of a case of onychomycosis doesn’t end with the detection of fungal hyphae. Trichophyton rubrum remains the most common cause of toenail fungus in the United States, but nondermatophyte molds – Scopulariopsis, Fusari.

see more →

Patient Education  2 results see all →